Article

Tumor Mutational Burden and Survival in Papillary Renal Cell Carcinoma Patients

2021-03-08

Abstract excerpt

<title>Abstract</title> <p><bold>Background</bold>: Papillary renal cell carcinoma (PRCC) is the second most prevalent subtype of renal cell carcinoma (RCC), accounting for 15% of all RCCs. Tumor mutational burden (TMB) is a promising prognostic factor in many types of cancers. The present study aimed to investigate the association between TMB and patient survival in PRCC patients.<bold>Methods</bold>: Genomic an...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: b5151022-6731-5d4b-8498-2b09cb14edd8
DOI: 10.21203/rs.3.rs-303671/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Tumor Mutational Burden and Survival in Papillary Renal Cell Carcinoma PatientsDOI 10.21203/rs.3.rs-303671/v1Read

Exploration of the relationships between tumor mutation burden with immune infiltrates in clear cell renal cell carcinomaSemantic proximity Read

Significance of Tumor Mutation Burden Related Immune Gene in the Progression and Prognosis of Clear Cell Renal Cell CarcinomaSemantic proximity Read

The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell CarcinomaSemantic proximity Read

Construction of a Prognostic Value Model in Papillary Renal Cell Carcinoma by Immune-Related GenesSemantic proximity Read

Identification of Potential Biomarkers Associated With Immune Infiltration in Papillary Renal Cell CarcinomaSemantic proximity Read

Comparison and validation of different risk models for papillary renal cell carcinomaSemantic proximity Read

Construction of a prognostic value model in papillary renal cell carcinoma by immune-related genes.Semantic proximity Read

Advanced papillary renal cell carcinoma: Epidemiology, genomic drivers, current therapies, and ongoing trials.Semantic proximity Read

A molecular subtype model of ccRCC based on immune-related genes for predicting immunotherapy responseSemantic proximity Read

An Immune-related Signature Predicted Survival in Patients With Kidney Papillary Cell CarcinomaSemantic proximity Read

CTLA4 has a profound impact on the landscape of tumor-infiltrating lymphocytes with a high prognosis value in clear cell renal cell carcinoma (ccRCC)Semantic proximity Read

Assessing the role of programmed cell death signatures and related gene TOP2A in progression and prognostic prediction of clear cell renal cell carcinomaSemantic proximity Read